| |
 |
|
Class Information
Number: 424/152.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) > Binds eukaryotic cell or component thereof or substance produced by said eukaryotic cell
Description: Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an integral or isolated part of a eukaryotic cell or with a substance produced by a eukaryotic cell.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618624 |
Weight control using an anti-lipase antibody |
Nov. 17, 2009 |
| 7618631 |
Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs |
Nov. 17, 2009 |
| 7604800 |
Anti-PSGL-1 antibodies |
Oct. 20, 2009 |
| 7597889 |
Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
Oct. 6, 2009 |
| 7595051 |
Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies |
Sep. 29, 2009 |
| 7563441 |
Anti-P-selectin antibodies |
Jul. 21, 2009 |
| RE40811 |
Peripheralization of hematopoietic stem cells |
Jun. 30, 2009 |
| 7553488 |
Antibodies against S100A8 and S100A9 proteins for modulating inflammatory reactions |
Jun. 30, 2009 |
| 7550143 |
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
Jun. 23, 2009 |
| 7550568 |
Monoclonal antibodies to human high molecular weight-melanoma associated antigen |
Jun. 23, 2009 |
| 7541032 |
Antigen uptake receptor for Candida albicans on dendritic cells |
Jun. 2, 2009 |
| 7527786 |
Methods for inhibiting the growth of cancer cells expressing PSCA |
May. 5, 2009 |
| 7501496 |
Anti-OX40L antibodies |
Mar. 10, 2009 |
| 7498030 |
Treatment with anti-ErbB2 antibodies and anti-hormonal compounds |
Mar. 3, 2009 |
| 7498032 |
Methods for treating immune disorders or cancer with anti-CD40 antibodies |
Mar. 3, 2009 |
| 7494651 |
TGF-.beta. binding antibodies |
Feb. 24, 2009 |
| 7485296 |
PSCA: prostate stem cell antigen and uses thereof in pancreatic cancer |
Feb. 3, 2009 |
| 7485302 |
Treatment with anti-ErbB2 antibodies and chemotherapeutic agents |
Feb. 3, 2009 |
| 7482007 |
Methods of inhibiting angiogenesis to treat cancer with alphavbeta3-specific antibodies |
Jan. 27, 2009 |
| 7482005 |
Methods of treating diseases with anti-VEGF antibodies |
Jan. 27, 2009 |
| 7476385 |
Methods of inhibiting IgE responses to thymus-dependent antigens with the anti-gp39 antibody MR1 |
Jan. 13, 2009 |
| 7465464 |
Populations of cells that express flk-2 receptors |
Dec. 16, 2008 |
| 7465580 |
Non-cytotoxic oriP replicon |
Dec. 16, 2008 |
| 7462352 |
Methods of treatng B-cell diseases using humanized anti-CD19 antibodies |
Dec. 9, 2008 |
| 7462353 |
Method for the treatment of inflammatory disorders |
Dec. 9, 2008 |
| 7456262 |
Methods and composition for modulating and detecting wisp activity |
Nov. 25, 2008 |
| 7455834 |
Methods and compositions for modulating and detecting WISP activity |
Nov. 25, 2008 |
| 7449186 |
Methods of blocking the interaction between stromal cells and hemopoietic cells with anti-VCAM-1 antibodies |
Nov. 11, 2008 |
| 7445798 |
Populations of cells that express FLK-1 receptors |
Nov. 4, 2008 |
| 7429381 |
Production and use of novel peptide-based agents for use with bi-specific antibodies |
Sep. 30, 2008 |
| 7425328 |
Tissue factor antibodies and uses thereof |
Sep. 16, 2008 |
| 7422738 |
Combined cancer treatment methods using antibodies to aminophospholipids |
Sep. 9, 2008 |
| 7413737 |
Anti-hydroxylase antibodies and uses thereof |
Aug. 19, 2008 |
| 7399471 |
Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use |
Jul. 15, 2008 |
| 7390490 |
Uses of anti-CX3CR1 antibody, anti-fractalkine antibody and fractalkine |
Jun. 24, 2008 |
| 7381413 |
Methods and products related to metabolic interactions in disease |
Jun. 3, 2008 |
| 7364734 |
Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist |
Apr. 29, 2008 |
| 7361345 |
Anti-CD40 antibodies capable of blocking B-cell activation |
Apr. 22, 2008 |
| 7354586 |
Methods of treating arthritis and diabetic retinopathy with .alpha..sub.v.beta..sub.3-specific antibodies |
Apr. 8, 2008 |
| 7344713 |
Decreased fat absorption with an anti-lipase antibody |
Mar. 18, 2008 |
| 7332568 |
Q3 SPARC deletion mutant and uses thereof |
Feb. 19, 2008 |
| 7329406 |
Methods of treating psoriasis with .alpha..sub.v.beta..sub.3-specific antibodies |
Feb. 12, 2008 |
| 7323171 |
Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction |
Jan. 29, 2008 |
| 7311911 |
Methods for inhibiting angiogenesis |
Dec. 25, 2007 |
| 7291333 |
Blockade of protein C activation reduces microvascular surgical blood loss |
Nov. 6, 2007 |
| 7288638 |
Fully human antibodies against human 4-1BB |
Oct. 30, 2007 |
| 7279158 |
Methods for the treatment of inflammatory joint disease |
Oct. 9, 2007 |
| 7270818 |
Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of DMS |
Sep. 18, 2007 |
| 7267819 |
Composition comprising and method of using angiopoietin-like protein 3 Angptl3 |
Sep. 11, 2007 |
| 7264807 |
Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
Sep. 4, 2007 |
|
|
|
